SELLAS Life Sciences Q3 EPS $(2.68) Vs. $(26.75) YoY

SELLAS Life Sciences (NASDAQ:SLS) reported quarterly losses of $(2.68) per share. This is a 89.98 percent increase over losses of $(26.75) per share from the same period last year.

Benzinga · 11/14/2019 21:35

SELLAS Life Sciences (NASDAQ:SLS) reported quarterly losses of $(2.68) per share. This is a 89.98 percent increase over losses of $(26.75) per share from the same period last year.